Gold tier: mechanically validated evidence, with its primary source.
238 evidence items · page 1 / 10
69.6 %Preoperative antibiotic use for caesarean section patients was 69.6% in 2021.
Sierra Leonesurgical site infectionsobserved 2021published 2023Tropical medicine and infectious diseaseeurope_pmcdocument of 5 observationsDOI 10.3390/tropicalmed8080385
55 testsMean quarterly HBV tests were 55 ± 6 during January–March in Freetown, Sierra Leone.
Sierra Leonehépatite Bobserved January-Marchpublished 2023Impact of COVID-19 on Hepatitis B Screening in Sierra Leone: Insights from a Community Phaeurope_pmcdocument of 8 observationsDOI 10.1101/2023.05.24.23290418
23.8 %Surgical prophylaxis was the second most common indication for antibiotic use, accounting for 23.8% of cases.
Sierra Leonesurgical prophylaxispublished 2023BMJ openeurope_pmcdocument of 14 observationsDOI 10.1136/bmjopen-2023-078367
288 sequencing_reagents288 sequencing reagents were delivered to Sierra Leone for Mpox diagnostics.
Sierra LeonempoxAfrica CDCdocument of 72 observations
26 %The likelihood of a positive HIV test was 26% lower in 2020 than in 2019 (prevalence ratio 0.74).
Sierra LeoneVIH/sidaobserved 2020published 2024AIDS and behavioreurope_pmcdocument of 7 observations
52.2 %Among 306 adult participants in Freetown, Sierra Leone, 52.2% had comprehensive HBV knowledge.
Sierra Leonehépatite Bpublished 2022Assessment of Knowledge, Stigmatizing Attitudes and Health-Seeking Behaviors Regarding Hepeurope_pmcdocument of 3 observationsDOI 10.20944/preprints202211.0233.v1
62.5 %Among eight participants with positive blood CrAg, cerebrospinal fluid CrAg was positive in five, representing 62.5%.
Sierra Leoneméningite cryptococciquepublished 2020BMC infectious diseaseseurope_pmcdocument of 7 observationsDOI 10.1186/s12879-020-4862-x
10 districtsLassa fever cases were observed in ten of Sierra Leone's thirteen districts.
Sierra Leonefièvre de Lassapublished 2014PLoS neglected tropical diseaseseurope_pmcdocument of 6 observations
8.2 %Enterococcus faecalis accounted for 8.2% of 49 bacterial isolates from surgical site infections.
Sierra Leonesurgical site infectionobserved February and July 2021published 2022Antimicrobial resistance and infection controleurope_pmcdocument of 15 observationsDOI 10.1186/s13756-022-01078-y
35.6 %In 2021, fewer people were tested for HIV than in 2019, representing a reduction of 35.6%.
Sierra LeoneVIH/sidaobserved 2021published 2024AIDS and behavioreurope_pmcdocument of 7 observations
39.3 %The prevalence of advanced HIV was 39.3% among inpatients aged 15 to 24 years with HIV at a major hospital in Sierra Leone between September 2022 and March 2023.
Sierra LeoneVIH avancéobserved September 2022 to March 2023published 2023Prevalence and factors associated with advanced HIV disease among young people aged 15 - 2europe_pmcdocument of 8 observationsDOI 10.1101/2023.11.07.23296880
9.34 aORRenal impairment was associated with proteinuria among people living with HIV, with an adjusted odds ratio of 9.34.
Sierra Leoneproteinuria · renal impairmentpublished 2022Journal of clinical medicineeurope_pmcdocument of 9 observations
16.1 %The prevalence of left ventricular hypertrophy (LVH) by electrocardiogram (ECG) among adults in Freetown, Sierra Leone was 16.1%.
Sierra Leoneleft ventricular hypertrophyobserved 2019–2021published 2023Burden of cardiometabolic risk factors and preclinical target organ damage among adults ineurope_pmcdocument of 8 observationsDOI 10.1101/2023.02.20.23286145
11.8 %Among pregnant women in Sierra Leone, M184V was found in 11.8% (n = 4/34) of cases.
Sierra LeoneVIH/sidapublished 2021Geneseurope_pmcdocument of 21 observationsDOI 10.3390/genes12091314
76.6 %Among children and adolescents in Sierra Leone, the most common HIV drug resistance-associated mutation was M184V, found in 76.6% (n = 49/64) of cases.
Sierra LeoneVIH/sidapublished 2021Geneseurope_pmcdocument of 21 observationsDOI 10.3390/genes12091314
Sierra Leone reported its first mpox case in 8 years in January 2025.
Sierra Leonempoxobserved January 2025published 2026Nature medicineeurope_pmcdocument of 4 observations
Sierra Leone, Liberia, and Guinea are hyperendemic West African countries for hepatitis B virus.
Guinée · Liberia · Sierra Leonehépatite Bpublished 2023Epidemiology and infectioneurope_pmcdocument of 3 observationsDOI 10.1017/s0950268823001735
24.5 %Serum lactate was elevated in 24.5% of the articles on COVID-19 patients with sepsis or septic shock.
Sierra LeoneCOVID-19 · sepsis · septic shockpublished 2020Sepsis and septic shock in COVID-19: a scoping review of the research dataeurope_pmcdocument of 17 observationsDOI 10.21203/rs.3.rs-30474/v1
92 patientsOf 701 drug-resistant TB patients, 92 (12.8%) were registered in the post-COVID-19 period.
Sierra Leonedrug-resistant TBobserved post-COVID-19published 2025Effect of the COVID-19 pandemic on drug-resistant tuberculosis treatment outcomes at a nateurope_pmcdocument of 9 observations
45.3 %Among children and adolescents in Sierra Leone, K103N was found in 45.3% (n = 29/64) of cases.
Sierra LeoneVIH/sidapublished 2021Geneseurope_pmcdocument of 21 observationsDOI 10.3390/genes12091314
66 %Weakness was present in 66% of patients with Ebola virus disease at presentation.
Sierra Leonemaladie à virus Ebolapublished 2014The New England journal of medicineeurope_pmcdocument of 14 observations
81.3 %Mechanical ventilation was documented in 81.3% of the articles on COVID-19 patients with sepsis or septic shock.
Sierra LeoneCOVID-19 · sepsis · septic shockpublished 2020Sepsis and septic shock in COVID-19: a scoping review of the research dataeurope_pmcdocument of 17 observationsDOI 10.21203/rs.3.rs-30474/v1
20.8 %Among 197 patients with chronic respiratory symptoms in an urban tertiary hospital in Sierra Leone, 41 (20.8%) were seropositive for Aspergillus.
Sierra LeoneAspergillusobserved November 2021 to July 2022published 2023PLoS neglected tropical diseaseseurope_pmcdocument of 9 observations
The analysis used national survey data from 2018 to 2020 of children aged 4–35 months to assess complete hepatitis B virus vaccination.
Sierra Leonehépatite Bobserved 2018-2020published 2023Epidemiology and infectioneurope_pmcdocument of 3 observationsDOI 10.1017/s0950268823001735
Poor adherence was significantly associated with virologic failure (p = 0.001).
Sierra LeoneVIH/sidaobserved 2019-2020published 2021Global health actioneurope_pmcdocument of 4 observationsDOI 10.1080/16549716.2021.1947566
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.